Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC).

Stress echocardiography is the combination of echocardiography with a physical, pharmacological, or electrical stress. The diagnostic endpoint for the detection of myocardial ischaemia is the induction of a transient worsening in regional function during stress. Stress echocardiography provides similar diagnostic and prognostic accuracy to radionuclide stress perfusion imaging, but at a substantially lower cost, without environmental impact, and with no biohazards for the patient and the physician. Among different stresses of comparable diagnostic and prognostic accuracy, semisupine exercise is the most used, dobutamine the best test for viability, and dipyridamole the safest and simplest pharmacological stress and the most suitable for combined wall motion coronary flow reserve assessment. The additional clinical benefit of myocardial perfusion contrast echocardiography and myocardial velocity imaging has been inconsistent to date, whereas the possibility of performing coronary flow reserve evaluation of the left anterior descending coronary artery by transthoracic Doppler echocardiography adds another potentially important dimension to stress echocardiography. New emerging fields of application taking advantage of the versatility of the technique are Doppler stress echo in valvular heart disease and in dilated cardiomyopathy. In spite of its dependence on the operator's training, stress echocardiography is today the best (most cost-effective and risk-effective) possible imaging choice to achieve the still elusive target of sustainable cardiac imaging in the field of non-invasive diagnosis of coronary artery disease. In 1935, Tennant and Wiggers1 demonstrated that coronary occlusion immediately resulted in instantaneous abnormality of wall motion. A large body of evidence2–5 recognized for the first time that transient dys-synergy was an early, sensitive, specific marker of transient ischaemia, clearly more accurate than ECG changes and pain. In European clinical practice,6–10 stress echo has been embedded in the legal and cultural framework of existing European laws and medical imaging referral guidelines. The …

[1]  L. Pierard,et al.  Low-level exercise echocardiography detects contractile reserve and predicts reversible dysfunction after acute myocardial infarction: comparison with low-dose dobutamine echocardiography. , 1999, Journal of the American College of Cardiology.

[2]  A. L'Abbate,et al.  Coronary Reserve and Exercise ECG in Patients With Chest Pain and Normal Coronary Angiograms , 1992, Circulation.

[3]  E. Picano,et al.  High dose dipyridamole echocardiography test in effort angina pectoris. , 1986, Journal of the American College of Cardiology.

[4]  M. Lauer,et al.  Prediction of mortality using dobutamine echocardiography. , 2001, Journal of the American College of Cardiology.

[5]  E. Picano,et al.  Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. , 2003, The American journal of cardiology.

[6]  Mandeep Singh,et al.  Risk stratification following acute myocardial infarction. , 2007, The Medical clinics of North America.

[7]  E Picano,et al.  Diagnosis of myocardial ischemia in hypertensive patients. , 2001, Journal of hypertension.

[8]  G. Minardi,et al.  The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. , 1996, Journal of the American College of Cardiology.

[9]  T. Ryan,et al.  Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography. , 1987, Journal of the American College of Cardiology.

[10]  G. Minardi,et al.  Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. , 1993, The American journal of medicine.

[11]  T. Marwick,et al.  Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. , 1997, Journal of the American College of Cardiology.

[12]  P. Pellikka,et al.  Prognostic value of exercise echocardiography in patients with classic angina pectoris. , 2004, The American journal of cardiology.

[13]  G. Mancia,et al.  Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[14]  H. Münzberg,et al.  Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. , 1996, The American journal of cardiology.

[15]  R. Štípal,et al.  Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction , 1999 .

[16]  T. Ryan,et al.  Symptoms, Adverse Effects, and Complications Associated With Dobutamine Stress. Echocardiography Experience in 1118 Patients , 1993, Circulation.

[17]  C. Wiggers,et al.  THE EFFECT OF CORONARY OCCLUSION ON MYOCARDIAL CONTRACTION , 1935 .

[18]  F. Pashkow,et al.  Accuracy and limitations of exercise echocardiography in a routine clinical setting. , 1992, Journal of the American College of Cardiology.

[19]  T. Marwick,et al.  Prediction of Mortality by Exercise Echocardiography: A Strategy for Combination With the Duke Treadmill Score , 2001, Circulation.

[20]  L. Hatle,et al.  Comparison of digital dipyridamole stress echocardiography and upright bicycle stress echocardiography for identification of coronary artery stenosis. , 1995, Cardiology.

[21]  E. Picano,et al.  Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. , 1987, The American journal of cardiology.

[22]  R. Senior,et al.  Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. , 1995, Journal of the American College of Cardiology.

[23]  E. Picano,et al.  Safety of intravenous high-dose dipyridamole echocardiography , 1992 .

[24]  C. Oakley,et al.  Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. , 1993, The American journal of cardiology.

[25]  J. Thomas,et al.  Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[26]  W. Armstrong,et al.  Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. , 1992, The American journal of cardiology.

[27]  S. Iliceto,et al.  Detection of coronary artery disease by digital stress echocardiography: comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography. , 1994, Journal of the American College of Cardiology.

[28]  E. Picano,et al.  Safety of stress echocardiography (from the International Stress Echo Complication Registry). , 2006, The American journal of cardiology.

[29]  C. Visser,et al.  Usefulness of two-dimensional exercise echocardiography shortly after myocardial infarction. , 1986, The American journal of cardiology.

[30]  E. Picano Sustainability of medical imaging , 2004, BMJ : British Medical Journal.

[31]  E. Picano,et al.  Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. , 1994, Lancet.

[32]  M. Hunink,et al.  Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. , 2007, American heart journal.

[33]  Nathaniel Reichek,et al.  Stress echocardiography , 1993, Current opinion in cardiology.

[34]  E. Picano,et al.  Stress echocardiography. From pathophysiological toy to diagnostic tool. , 1992, Circulation.

[35]  E. Picano,et al.  The comparable diagnostic accuracies of dobutamine‐stress and dipyridamole‐stress echocardiographies: a meta‐analysis , 2000, Coronary artery disease.

[36]  J. Seward,et al.  Safety of dobutamine stress echocardiography supervised by registered nurse sonographers. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  E. Picano Dipyridamole-echocardiography test: historical background and physiologic basis. , 1989, European heart journal.

[38]  M. Verani,et al.  Exercise Echocardiography Versus 201TI Single‐Photon Emission Computed Tomography in Evaluation of Coronary Artery Disease: Analysis of 292 Patients , 1992, Circulation.

[39]  J. Cornel,et al.  Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. , 1994, The American journal of cardiology.

[40]  A. Djordjević-Dikić,et al.  Stress Echocardiography in the Detection of Myocardial Ischemia: Head‐to‐Head Comparison of Exercise, Dobutamine, and Dipyridamole Tests , 1994, Circulation.

[41]  J. Roelandt,et al.  Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? , 1994, The American journal of cardiology.

[42]  T. Marwick,et al.  A gatekeeper for the gatekeeper: inappropriate referrals to stress echocardiography. , 2007, American heart journal.

[43]  F. Fedele,et al.  Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. , 1995, Journal of the American College of Cardiology.

[44]  P. Pellikka,et al.  Prognostic significance of the location of wall motion abnormalities during exercise echocardiography. , 2002, Journal of the American College of Cardiology.

[45]  Rita A. Longaker,et al.  Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[46]  J. Seward,et al.  Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. , 2002, Journal of the American College of Cardiology.

[47]  E. Picano,et al.  Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. , 1992, The American journal of cardiology.

[48]  J R Roelandt,et al.  Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. , 1994, The American journal of medicine.

[49]  P. Nihoyannopoulos,et al.  Absence of myocardial dysfunction during stress in patients with syndrome X. , 1991, Journal of the American College of Cardiology.

[50]  Jeroen J. Bax,et al.  Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. , 1999, Journal of the American College of Cardiology.

[51]  A. Salustri,et al.  Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. , 1998, Circulation.

[52]  E. Picano,et al.  Cardiac functional stress imaging: A sequential approach with stress echo and cardiovascular magnetic resonance , 2007, Cardiovascular ultrasound.

[53]  R. Semelka,et al.  The American College of Radiology white paper on radiation dose in medicine:deep impact on the practice of cardiovascular imaging , 2007, Cardiovascular ultrasound.

[54]  E. Fleck,et al.  Current clinical applications of stress wall motion analysis with cardiac magnetic resonance imaging. , 2005, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[55]  E. Picano,et al.  The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis , 2008, Cardiovascular ultrasound.

[56]  E. Picano,et al.  Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. , 1996, Journal of the American College of Cardiology.

[57]  E. Picano,et al.  Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study , 1994, The Lancet.

[58]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[59]  Adelaide M. Arruda-Olson,et al.  Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? , 2002, Journal of the American College of Cardiology.

[60]  M. Matsuda,et al.  Dissociation between regional myocardial dysfunction and ECG changes during myocardial ischemia induced by exercise in patients with angina pectoris. , 1983, American heart journal.

[61]  J R Roelandt,et al.  Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. , 1997, Journal of the American College of Cardiology.

[62]  I. Vuori,et al.  Comparison of bicycle, heavy isometric, dipyridamole-atropine and dobutamine stress echocardiography for diagnosis of myocardial ischemia. , 1999, The American journal of cardiology.

[63]  Stephen E. Brown,et al.  Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. , 1992, Journal of the American College of Cardiology.

[64]  L. Monserrat,et al.  Comparison of exercise echocardiography to exercise electrocardiographic testing added to echocardiography at rest for risk stratification after uncomplicated acute myocardial infarction. , 2003, The American journal of cardiology.

[65]  R. Bonow,et al.  Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.

[66]  J. Seward,et al.  Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. , 1995, Mayo Clinic proceedings.

[67]  A. Salustri,et al.  Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. , 1992, European heart journal.

[68]  René M. Botnar,et al.  Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.

[69]  E. Picano,et al.  Dipyridamole-echocardiography test in effort angina pectoris. , 1985, The American journal of cardiology.

[70]  E. Picano,et al.  The value of ECG and echocardiography during stress testing for identifying systemic endothelial dysfunction and epicardial artery stenosis. , 2002, European heart journal.

[71]  J. Rivera,et al.  Prognostic value of exercise echocardiography: validation of a new risk index combining echocardiographic, treadmill, and exercise electrocardiographic parameters. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[72]  A. Støylen,et al.  Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. , 2007, Journal of the American College of Cardiology.

[73]  Louis Labrousse,et al.  Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. , 2008, Journal of the American College of Cardiology.

[74]  E. PlCANO Dipyridamole-echocardiography test: historical background and physiologic basis , 1989 .

[75]  V. Positano,et al.  Head to head comparison between perfusion and function during accelerated high-dose dipyridamole magnetic resonance stress for the detection of coronary artery disease. , 2008, The American journal of cardiology.

[76]  L. Pierard,et al.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. , 1986, The American journal of cardiology.

[77]  A. Weyman,et al.  Exercise cross-sectional echocardiography in ischemic heart disease. , 1979, Circulation.

[78]  E. Picano,et al.  The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. , 2001, European heart journal.

[79]  P. Nihoyannopoulos,et al.  Evaluation of dipyridamole-Doppler echocardiography for detection of myocardial ischemia and coronary artery disease. , 1991, The American journal of cardiology.

[80]  Eugenio Picano,et al.  Stress echo results predict mortality: a large-scale multicenter prospective international study. , 2003, Journal of the American College of Cardiology.

[81]  R. Kerber,et al.  Echocardiographic Detection of Regional Myocardial Infarction: An Experimental Study , 1973, Circulation.

[82]  Jeroen J. Bax,et al.  Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. , 1998, Diabetes care.

[83]  P. Rigo,et al.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[84]  E. Picano,et al.  Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. , 1992, The American journal of cardiology.

[85]  Michael J Pentecost,et al.  American College of Radiology white paper on radiation dose in medicine. , 2007, Journal of the American College of Radiology : JACR.

[86]  M. Crawford,et al.  Usefulness of two-dimensional echocardiography during low-level exercise testing early after uncomplicated acute myocardial infarction. , 1987, The American journal of cardiology.

[87]  E. Picano,et al.  Dobutamine Stress Echocardiography , 2000, Drug safety.

[88]  E. Picano,et al.  Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. , 2001, The American journal of cardiology.

[89]  A. Elhendy,et al.  Can stress echocardiography compete with perfusion scintigraphy in the detection of coronary artery disease and cardiac risk assessment? , 2000, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[90]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[91]  J A Koziol,et al.  Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. , 1984, The American journal of physiology.

[92]  A. Neskovic,et al.  Positive high-dose dipyridamole echocardiography test after acute myocardial infarction is an excellent predictor of cardiac events. , 1995, American heart journal.

[93]  J. Leppo,et al.  Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[94]  James D. Thomas,et al.  Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography. , 2003, European heart journal.

[95]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[96]  K. Sagar,et al.  Dobutamine stress echocardiography for risk stratification after myocardial infarction. , 1997, Circulation.

[97]  E. Picano,et al.  Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. , 1994, Circulation.

[98]  L. Crouse,et al.  Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary arteriography. , 1991, The American journal of cardiology.

[99]  T. Ryan,et al.  Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. , 1987, American heart journal.

[100]  P A Poole-Wilson,et al.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. , 1995, Journal of the American College of Cardiology.

[101]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[102]  W. Mathias,et al.  Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4,033 consecutive studies. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[103]  Eugenio Picano,et al.  Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno , 2004, BMJ : British Medical Journal.

[104]  Jeroen J. Bax,et al.  Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation , 2005, Heart.

[105]  A. Salustri,et al.  Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[106]  L. Tavazzi,et al.  Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy , 2003, Cardiovascular Ultrasound.

[107]  J. Peteiro,et al.  Prognostic value of exercise echocardiography in patients with diabetes mellitus and known or suspected coronary artery disease. , 2005, The American journal of cardiology.

[108]  A. Morabito,et al.  RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations. , 1998, Giornale italiano di cardiologia.

[109]  J J Bax,et al.  Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. , 1996, Journal of the American College of Cardiology.

[110]  R. Gibbons Leading the elephant out of the corner: the future of health care: presidential address at the American Heart Association 2006 scientific sessions. , 2007, Circulation.

[111]  E. Picano,et al.  Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. , 1996, European heart journal.

[112]  G. Minardi,et al.  The atropine factor in pharmacologic stress echocardiography , 1996 .

[113]  R. Redberg,et al.  The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[114]  Jeroen J. Bax,et al.  Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. , 2001, Current problems in cardiology.

[115]  E. Picano,et al.  Transient changes in left ventricular mechanics during attacks of Prinzmetal's angina: an M-mode echocardiographic study. , 1984, American heart journal.

[116]  E. Picano,et al.  Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. , 1989, Circulation.

[117]  S. Kaul,et al.  Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. , 1999, Journal of the American College of Cardiology.

[118]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[119]  L. Rydén,et al.  Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. , 1995, The American journal of cardiology.

[120]  E. Picano Stress echocardiography: a historical perspective. , 2003, The American journal of medicine.

[121]  M. J. Conley,et al.  Prognostic value of a normal exercise echocardiogram. , 1990, American heart journal.

[122]  P. Pellikka,et al.  Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. , 2001, The American journal of medicine.

[123]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[124]  B. Beleslin,et al.  Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease , 2006, Cardiovascular ultrasound.

[125]  R. Štípal,et al.  Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. , 1998, Journal of the American College of Cardiology.

[126]  Miguel A García,et al.  Evaluación de la seguridad de la ecocardiografía de estrés en España y Portugal , 2001 .

[127]  M. Lauer,et al.  Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. , 1999, Journal of the American College of Cardiology.

[128]  S. Chierchia,et al.  Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization : a novel test for detecting myocardial viability. , 2000, Circulation.

[129]  F. Fernández‐Avilés,et al.  Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. , 1996, Chest.

[130]  D Franklin,et al.  Regional Myocardial Function during Acute Coronary Artery Occlusion and Its Modification by Pharmacologic Agents in the Dog , 1974, Circulation research.

[131]  J. Ross Mechanisms of regional ischemia and antianginal drug action during exercise. , 1989, Progress in cardiovascular diseases.

[132]  C. Oakley,et al.  Dobutamine stress echocardiography for detection and assessment of coronary artery disease. , 1992, Journal of the American College of Cardiology.